What's New in Health and Life Sciences

News from the European Comission

EUROPA - Research and Innovation: Health & Life Sciences

EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Health research and innovation web site. For more RSS news feeds visit
For more RSS news feeds click the link above.
ImageIndustrial applications often call for surfaces designed to attract or repel water. EU-funded researchers are devising new methods to characterise and manufacture such surfaces and will make their findings public in a new Open Innovation Environment.
ImageEU-funded researchers are aiming to develop a new class of drugs to treat and even cure multiple sclerosis, building on groundbreaking research into previously unexploited mechanisms of an ancestral metabolic molecule the helps regulate the immune system of all humans and mammals.
One of the first 18 research and innovation projects funded by the EU to tackle the coronavirus is already delivering results. Researchers involved in the “HG nCoV19 test” project, selected for funding from the EU research and innovation programme Horizon 2020 under the special call launched in January, have obtained approval to put a new rapid point-of-care diagnostic for COVID-19 on the market.

Innovative and rapid health-related approaches to respond to COVID-19 and to deliver quick results for society for a higher level of preparedness of health systems.
20 May 2020 - 14:00-16:30

This second call for an Expression of Interest implements Action 3 of the ERAvsCorona Action Plan, which resulted from dialogues between the Commission services and the national ministries over the period March-April 2020. The full title of Action 3 is ‘New funding for innovative and rapid health-related approaches that respond to COVID-19 and deliver quick results relevant to society and a higher level of preparedness of health systems’. In line with the Pledge for the Coronavirus Global Response launched on 4 May 2020, it is of paramount importance that new solutions need to be available and affordable for all.

This second call for an expression of interest complements the first expression of interest that the European Commission published in January 2020, which led to the funding of 18 projects in March 2020. The first expression of interest focused on advancing the knowledge on SARS-CoV-2 and its impact on infected persons, with the aim of contributing to an efficient patient management and/or public health preparedness and response.

ImageA single test strip - the first platform to couple a methanol fuel cell with a biosensor - could act as a self-powered, easy-to-use, disposable, and low-cost test for diseases such as cancer, say EU-funded researchers.
ImageArmed with a novel biosensor that uses acoustic waves to detect tumour DNA, an EU-funded project could increase the precision and affordability of cancer diagnosis and help make personalised treatment a reality for more patients.
ImageGenerating safe antigens to induce immunity is one of several key steps in vaccine production. Purification is another, and it is typically a complex process. EU-funded researchers have designed a way to simplify the process, boost yields, limit waste and reduce costs, in a bid to help make more doses available more affordably.
ImageEU-funded researchers have developed an ultrasensitive test to rapidly, accurately and cost-effectively diagnose disease, underpinned by innovative biosensing technology that could help combat the COVID-19 pandemic, HIV and cancer.
ImageEU-funded researchers have employed quantum physics to develop an optical microscope that opens up the potential to view the tiniest of objects - including many viruses - directly for the first time.


PRONIA Workpackages

For Help-seekers and Relatives

For Help-seekers and Relatives Für Hilfesuchende und Angehörige
Per Pazienti e Parenti Potilaille ja Omaisille

Newsletter Subscription

Please fill in the information of your subscription.


News Section

No news available.

Press Area

+++ Information about PRONIA for the Press and Press Events +++

+++ Latest PRONIA Publications +++